The present invention provides a mouthwash composition comprising a heterogeneous gel, wherein said heterogeneous gel comprises at least two gelling agents and two or more active ingredients, and wherein the composition provides the differential release of the active ingredients over a period of time.
|
1. An edible mouthwash composition comprising a heterogeneous gel comprising two or more gels which are blended together but not homogenized, and two or more active ingredients:
wherein said heterogeneous gel comprises: (i) a first gel comprising a surfactant, a first gelling agent and one or more active ingredients; and (ii) a second gel comprising a second gelling agent and one or more active ingredients,
wherein the first and second gelling agents are selected from xanthan gum, gellan gum, gum arabic, guar gum, locust bean gum, methylcellulose, carboxymethyl cellulose, gelatin, carrageenan, agar and pectin;
one of said active ingredients is xylitol;
the other of said active ingredient(s) is selected from the group consisting of flavourants, antiseptics, antibiotics, anticaries agents, tartar control agents, oral cleaning agents, abrasive agents, desensitizing agents, sweetening agents, medicaments, pro-drugs, activating agents for activating pro-drugs, pH-buffering agents, cooling agents, herbal agents, vitamins and combinations thereof,
the composition has a viscosity of from 1000 to 2000 c.p. at 20° C.; and
the composition provides differential release of the active ingredients over a period of time.
2. The mouthwash composition according to
3. The mouthwash composition according to
4. The mouthwash composition according to
5. The mouthwash composition according to
6. The mouthwash composition according to
7. The mouthwash composition according to
8. A method of preparing a mouthwash composition in the form of a gel as claimed in
providing a first component;
providing a second component; and
mixing the first and second components together to provide a heterogeneous mixture,
wherein the first and second components each comprises at least one active ingredient, and
the composition comprises two or more active ingredients.
9. The method according to
10. The method according to
11. The method of
12. The method according to
13. The method according to
15. A method of cleaning teeth and/or freshening breath in a subject comprising administering the mouthwash composition as claimed in
16. The method according to
17. The method according to
18. The method according to
19. The method according to
20. The mouthwash composition according to
|
The present invention provides a mouthwash composition, a process for its preparation, a package comprising a single dose or unit of the mouthwash composition, and the use of the mouthwash composition to deliver active ingredients.
A conventional mouthwash is a liquid which is swilled around the mouth and sometimes gargled before being discarded. A conventional mouthwash is employed primarily to clean the mouth and freshen the breath. Conventional mouthwashes are not convenient for use away from the home, for example, when at work or eating out, since they are not intended to be consumed. Many conventional mouthwashes also have a very strong unpleasant taste or even provide a burning sensation when retained within the mouth for an extended period of time. For this reason, it is believed that less than half of the UK population uses mouthwash. Many mouthwashes are also not suitable for children.
The present invention, which relates to a mouthwash composition in the form of a gel, has been devised with these issues in mind.
It is known in the art to employ gels in oral hygiene products such as toothpastes and mouthwashes—see, for example, WO 2014/059679, WO 90/00387, WO 2014/156505, JP 2012193150, JP 2004300119 and JP 2003081794. WO 2014/059679 discloses a method for making a toothpaste composition, which comprises the following steps:
There is, however, no disclosure in any of these documents of a mouthwash composition which provides a differential release of its active ingredients over a period of time. Thus, there is still a need for further and improved mouthwash compositions.
According to a first aspect, the present invention provides a mouthwash composition comprising a heterogeneous gel, wherein said heterogeneous gel comprises at least two gelling agents and two or more active ingredients, and wherein the composition provides differential release of the active ingredients over a period of time. Preferably the mouthwash composition of the present invention sequentially releases an effective amount of the two or more active ingredients over a period of time. This means that at least two of the active ingredients in the composition reach an effective amount or concentration in situ after different periods of time have elapsed after placing the mouthwash composition in a mouth.
As used herein, a “mouthwash composition” is a composition which is intended to be held temporarily in the mouth and is suitable for cleaning, freshening breath and/or the delivery one or more active components to the mouth. It will thus be understood that the term “mouthwash” does not imply a liquid composition. As the mouthwash composition of the present invention is not intended to be used in combination with a toothbrush, it will also be understood that the term “mouthwash” does not include toothpaste.
The mouthwash of the invention provides a different experience for the consumer since it is in the form of a gel. The gel can be squeezed though the teeth and therefore encourages the consumer to retain the product in the mouth for longer. The gel consistency thus enables the mouthwash to provide release of an active ingredient over a longer period of time than is typically achieved with conventional liquid mouthwashes. Moreover the mouthwash composition of the present invention is preferably edible. Unlike conventional mouthwashes and toothpastes, which are mainly spat out of the mouth after use, the mouthwash composition of the present invention is intended to be swallowed. Advantageously this makes the mouthwash composition of the present invention easy to use when the user is away from home and also by a range of different types of people, including children.
In some embodiments the composition is capable of forming a film on a buccal surface, such as the surface of a tooth (i.e. a biocomposite), gum, cheeks and/or tongue. In one embodiment the composition provides a film which remains on the surface for a duration of at least 3 minutes, at least 5 minutes, at least 8 minutes or at least 10 minutes. In some embodiments the film may be completely lost after 10 minutes.
The film may be formed rapidly after the mouthwash is placed in the mouth. The film may provide an interface between the rest of the gel in the buccal cavity and the surfaces of the mouth, in particular the teeth. Without being bound by theory, it is believed that as molecules are released from the bulk of the mouthwash composition, they are then adsorbed into the film before passing onto the mouth or tooth surface. The film thus allows molecules to be adsorbed from the contents of the buccal cavity. The delivery of active ingredients to the film from the bulk of the composition, and the loss from the film into the tooth or other mouth surface, are balanced to provide an effective half-life of the composition. The extended residence time of the film on the surfaces of the mouth, as compared to conventional liquid mouthwashes, provides enhanced exposure to active ingredients present in the composition.
The mouthwash composition of the present invention preferably comprises: (i) a first gel comprising a surfactant, a first gelling agent and optionally one or more active ingredients; and (ii) a second gel comprising a second gelling agent and one or more active ingredients. Preferably the affinity of the surfactant for the first gel is lower than the affinity of at least one of the one or more active ingredients for the first gel and/or the second gel.
Preferably, when the mouthwash composition is placed in a mouth, the surfactant is readily released from the first gel into the buccal cavity. Preferably therefore the surfactant concentration reaches an effective amount in the buccal cavity prior to at least one of the other one or more active ingredients achieving an effective amount thereof. Particularly preferably the composition sequentially releases an effective amount of the surfactant and then an effective amount of at least one of the one or more active ingredients over a period of time. By the term “effective amount” is meant the amount or concentration that is necessary for an ingredient to have its desired effect. This term may also be described as an effective dose. Thus the “effective amount” of any given active ingredient will be different. For example, the “effective amount” of surfactant is likely to be different to the “effective amount” of sweetening agent. The preferred mouthwash compositions of the present invention sequentially release an effective amount of surfactant prior to at least one of the other one or more active ingredients. This means that the amount or concentration of surfactant reaches the level required to facilitate the formation of a film of the composition on the teeth and remove oils and fats from the teeth, prior to the amount or concentration of at least one of the other one or more active ingredients reaching its effective amount.
The mouthwash composition of the present invention releases an effective amount of surfactant in a relatively short period of time after the composition is placed in a mouth. Advantageously the surfactant facilitates the formation of the above-mentioned film on the surfaces of the mouth, and in particular the teeth. The teeth tend to be covered with fats and oils after the consumption of food and the hydrophobic part of the surfactant readily interacts therewith. This helps to remove these compounds from the teeth surfaces prior to their contact with other active ingredients of the composition, such as NaF, which otherwise might not reach the teeth surfaces. Furthermore the surfactant also helps to ensure that there is homogeneity between the mouthwash composition and the saliva.
Preferably the mouthwash composition of the present invention also releases an effective amount of pH-buffering agent in a relatively short period of time after the composition is placed in a mouth. Like the surfactant, the pH-buffering agent, helps to prepare the tooth surface for formation of a film and for treatment by other active ingredients. Preferably therefore the composition sequentially releases an effective amount of the surfactant and an effective amount of a pH-buffering agent and then an effective amount of at least one of the one or more active ingredients over a period of time.
As mentioned above the mouthwash composition of the present invention preferably forms a film upon contact with a buccal surface. It is an advantage of the present invention that the film increases the residence time of the one or more active ingredients on the buccal surface. By “residence time” is meant the time for which the given active ingredient is in contact with a buccal surface. With a conventional liquid mouthwash composition, the residence time of the active ingredients present therein is generally the same as the time for which the mouthwash composition is retained in the mouth before being spat out. With the mouthwash composition of the invention, which is in the form of a gel that preferably forms a film upon contact with a buccal surface, the residence time is significantly increased because after the majority of the composition has been swallowed, the film remains on the surface of the teeth and retains the one or more active ingredients therein, where they are in contact with the buccal surface.
The mouthwash composition of the present invention preferably is retained in the mouth for up to 180 seconds, e.g. 30 to 180 seconds. More preferably the mouthwash composition is retained in the mouth for 60 to 180 seconds or 120 to 180 seconds. By the phrase “retained in the mouth” is meant the duration of time for which substantially the entirety of the mouthwash composition is present in the mouth of a user, i.e. the time between placing the mouthwash composition in the mouth and removal of the mouthwash composition from the mouth. Preferably the mouthwash composition is swallowed at the end of this time.
Preferably the mouthwash composition of the present invention has a longer residence time in the mouth than the time for which it is retained in the mouth. Preferably the mouthwash composition has a residence time of greater than 180 s. Preferably the mouthwash composition provides release of the active ingredients over a period of time of greater than 180 s. This may be achieved by the mouthwash composition of the present invention because, as described above, it forms a film on the buccal surface. Active ingredients may be advantageously retained in this film after the majority of the composition is swallowed and provide further release of active ingredients.
In some embodiments the composition is edible, i.e. the composition is intended to be consumed in its entirety. An edible composition is particularly convenient for use at work, when travelling or when eating out. An edible composition is also suitable for children.
The composition comprises a heterogeneous gel. By “heterogeneous” it will be understood that the composition comprises two or more gels which are blended together. One or more of the gels may be hydrogels.
The present invention therefore also provides a mouthwash composition comprising a heterogeneous gel, wherein said heterogeneous gel comprises: (i) a first gel comprising a surfactant, a first gelling agent and optionally one or more active ingredients; and (ii) a second gel comprising a second gelling agent and one or more active ingredients, wherein the affinity of said surfactant for said first gel is lower than the affinity of at least one of said one or more active ingredients for said first gel and/or said second gel.
The heterogeneous gel contains at least two gelling agents. In some embodiments, the gelling agents are selected from the group consisting of xanthan gum, gellan gum, gum arabic, guar gum, locust bean gum, methylcellulose, carboxymethyl cellulose, gelatin, carrageenan, agar and pectin. The at least two gelling agents may be different (such as methylcellulose and gelatin), or they may be different forms of the same gelling agent (such as gellan gum low acyl (e.g. type F) and gellan gum high acyl (e.g. type LT100)). The present inventors have found that these gelling agents provide a suitable texture in the mouth.
In some embodiments the heterogeneous gel comprises methylcellulose and xanthan gum. Preferably the first gel, additionally comprising a surfactant, comprises xanthan gum. Preferably the second gel comprises methylcellulose.
In some embodiments the heterogeneous gel comprises gellan gum, preferably low-acyl gellan gum and high-acyl gellan gum, and optionally gelatin. Preferably the first gel, additionally comprising a surfactant, comprises high-acyl gellan gum. Preferably the second gel comprises low-acyl gellan gum.
Preferably the mouthwash composition of the present invention further comprises a sweetening agent. Preferably the composition sequentially releases: (i) an effective amount of the surfactant and an effective amount of the sweetening agent; and (ii) an effective amount of the one or more active ingredients. When a pH-buffering agent is additionally present, the composition preferably sequentially releases (i) an effective amount of the surfactant, an effective amount of the pH-buffering agent and an effective amount of the sweetening agent; and then (ii) an effective amount of the one or more active ingredients. Preferably the sweetening agent is released in effective amount relatively quickly after the mouthwash composition is placed in the mouth so that it can mask the taste of other unpleasant tasting active ingredients.
The at least one or more active ingredient may be selected from the group consisting of humectants (e.g. sorbitol), flavourants, colourings or pigments, antiseptics, antimicrobials (including antibiotics, antivirals and antifungals), anticaries agents (e.g. zinc citrate, zinc gluconate), anticalculus agents (i.e. tartar control agents), oral cleaning agents, abrasive agents, desensitizing agents (e.g. inorganic ions such as K+), strengthening agents (e.g. fluoride ion sources such as sodium fluoride), bleaching or whitening agents, sweeteners (e.g. polyols), medicaments, pH-modifying agents, surfactants, cooling agents, herbal agents, vitamins and combinations thereof. Preferably the at least one or more active ingredient is selected from the group consisting of humectants (e.g. sorbitol), flavourants, colourings or pigments, antiseptics, antimicrobials (including antibiotics, antivirals and antifungals), anticaries agents (e.g. zinc citrate, zinc gluconate), anticalculus agents (i.e. tartar control agents), oral cleaning agents, abrasive agents, desensitizing agents (e.g. inorganic ions such as K+), strengthening agents (e.g. fluoride ion sources such as sodium fluoride), bleaching or whitening agents, medicaments, cooling agents, herbal agents, vitamins and combinations thereof. It will be understood that a single ingredient may have more than one effect.
Suitable flavourants include peppermint oil, menthol, eucalyptus oil, vanillin, sage, thymol, marjoram, parsley oil, spearmint oil, cinnamon oil, oil of wintergreen (methyl salicylate), clove oil, bay oil, anise oil, citrus oils, and fruit oils and essences including those derived from lemon, orange, lime, grapefruit, apricot, banana, grape, apple, strawberry, cherry, and pineapple.
In some embodiments, the flavorant comprises peppermint oil, menthol, eucalyptol, and/or thymol.
In some preferred embodiments the composition comprises a surfactant. A surfactant provides surface wetting properties and therefore helps the film adhere to the surface of the tooth, gum, cheek and/or tongue.
Suitable surfactants include sorbitan monolaurate, sodium lauryl sulfate, sodium coconut monoglyceride sulfonate, sodium lauryl sarcosinate, sodium lauryl isoethionate, sodium laureth carboxylate, sodium dodecyl benzenesulfonate, poloxamers, polyoxyethylene sorbitan esters, fatty alcohol ethoxylates, alkylphenol ethoxylates, tertiary amine oxides, tertiary phosphine oxides, and dialkyl sulfoxides. In one embodiment the surfactant is sorbitan monolaurate.
In one series of embodiments the composition comprises at least 0.01 wt %, at least 0.05 wt % or at least 0.1 wt % surfactant.
In some embodiments the composition comprises a sweetener. The sweetener may be selected from dextrose, sucrose, maltose, dextrin, dried invert sugar, mannose, xylose, ribose, fructose, levulose, galactose, corn syrup (including high fructose corn syrup and corn syrup solids), partially hydrolyzed starch, hydrogenated starch hydrolysate, mannitol, sorbitol, xylitol, maltitol, isomalt, and combinations thereof. In one embodiment the sweetener comprises xylitol. Xylitol is known to be beneficial for the teeth.
In one series of embodiments the composition comprises at least 3 wt %, at least 5 wt % or at least 10 wt % sweetener. In one series of embodiments the composition comprises no more than 50 wt %, no more than 30 wt % or no more than 20 wt % sweetener.
In some embodiments the composition comprises a pH modifying agent. This may be employed to provide pH buffering at the tooth, cheek and/or tongue surface to neutral pH. Modifying the pH at the surface helps to prepare the surface to facilitate the delivery of other active ingredients to the surface.
In some embodiments, the composition is capable of providing the differential release of active ingredients over a period of time.
By “differential release” it will be understood that the active ingredients are released at different rates. In some embodiments, a first active ingredient may be released entirely, followed by the release of a second active ingredient. However, it is not necessary that the active ingredients are released consecutively, and the release of different active ingredients may overlap. For example, in some embodiments a first active ingredient may be released at a rapid rate initially and then at a slower rate, while the rate of release of a second active ingredient increases gradually, or remains substantially constant. The release of one or more of the active ingredients may be delayed, such that the ingredient is not released straightaway on placing the composition into the mouth. The composition therefore enables the release of different active ingredients in sequence.
In some embodiments, the composition may be formulated such that the active ingredients are released in two more phases. The phases may be sequential. For example, in a first phase film formation, surface wetting and/or pH buffering may occur. In a second phase an antimicrobial agent may be released. In a third phase inorganic ions such as K+ for desensitization may be released. In some embodiments the phases may overlap.
The sequence of release of different active ingredients may conveniently be tailored in accordance with a desired effect (e.g. dental hygiene). A preferred mouthwash composition of the present invention provides the differential release, and more preferably sequential release of an effective amount, of at least a surfactant, a sweetening agent and at least one of the one or more active ingredients, preferably flavourants, antiseptics, antimicrobials, anticaries agents, anticalculus agents, oral cleaning agents, abrasive agents, desensitizing agents, strengthening agents, bleaching or whitening agents, medicaments, cooling agents, herbal agents, vitamins and combinations thereof. Preferably the mouthwash composition of the invention sequentially releases an effective amount of a surfactant and an effective amount of a sweetening agent and then an effective amount of one or more active ingredients selected from flavourants, antiseptics, antimicrobials, anticares agents, anticalculus agents, oral cleaning agents, abrasive agents, desensitizing agents, strengthening agents, bleaching or whitening agents, medicaments, cooling agents, herbal agents, vitamins and combinations thereof.
The composition may be capable of providing the release of one or more of the active ingredients over a period of time of at least 2 minutes, at least 3 minutes, at least 5 minutes, at least 8 minutes, at least 10 minutes or at least 15 minutes.
For example, the composition may be formulated to provide film formation, surface wetting and/or pH buffering initially, so as to prepare the surface of the tooth, gum, cheek and/or tongue. The composition may then release one or more further active ingredients to the prepared surface, such as antimicrobials and/or desensitizers.
The differential or sequential release of different active ingredients can be achieved in numerous ways, many of which will be known to those skilled in the art. For example, the release of an active ingredient may be controlled by the affinity of the active ingredient for one or both of the gels forming the heterogeneous gel. The higher the affinity of the active ingredient for the gel, the slower the release. The release of an active ingredient may also be controlled by the concentration of the active ingredient in the gel, by the viscosity of the gel(s), by the overall structure of the heterogeneous gel and so on. The skilled man can readily determine the release rate of any active ingredient from a given gel in the presence of water by standard test procedures wherein the gel is placed in water and the change in concentration of the active ingredient in water is measured over time.
An active ingredient may be associated with one or more gels of the heterogeneous gel. In some embodiments, and as described above, the composition may comprise one or more active ingredients associated with a first gel, and one or more active ingredients associated with a second gel. The active ingredient(s) associated with the first gel may be same or different to those associated with the second gel. By “associated with”, it will be appreciated that the active ingredient(s) is suspended or dispersed within the gel matrix. The active ingredient(s) may have an affinity for the gel which can vary in strength, for example from being physically trapped within the gel matrix to being weakly bound to the gel e.g. by hydrogen bonding. As the gel is broken down by the effects of mastication, temperature, pH, salivary amylase, salinity and/or hydration, the active ingredient(s) is released.
In some embodiments, the two or more gels differ from each other in their hydrophilicity. For example, the composition may comprise a first gel and a second gel, wherein the first hydrogel is more hydrophilic than the second gel.
In some embodiments, the (or one of the) active agent(s) is constituted by or comprises a pro-drug. The pro-drug may be activated in situ in the mouth by, for example, the action of salivary amylase or temperature. In some embodiments, the composition may further comprise an activating agent (e.g. a separating agent or enzyme) for activating the pro-drug. The pro-drug is then activated once the activating agent is released from the gel. The composition may be formulated such that the activating agent is released after the pro-drug, or release of the activating agent is initiated after release of the pro-drug is initiated. This enables controlled activation of the pro-drug.
The mouthwash composition of the invention may be similar in texture to a sports gel. The composition may have a viscosity of from 1000 to 2000 or from 1200 to 1800 c.p. at 20° C. A sports-gel style mouthwash is better for moving around the mouth during mastication. The temptation to swallow is low, with the dissolution into the mouth being very effective. A jelly or sweet-like mouthwash may be particularly appealing for children.
In some embodiments, the mouthwash composition has a viscosity of no greater than 500,000, no greater than 250,000, no greater than 100,000, no greater than 50,000, no greater than 30,000, no greater than 20,000, no greater than 10,000 or no greater than 5000 c.p. at 20° C., In some embodiments, the mouthwash composition has a viscosity of from 2000 to 500,000, from 5,000 to 300,000, from 10,000 to 100,000 or from 25,000 to 70,000 c.p. at 20° C.
In some embodiments, the mouthwash composition is similar in texture to a jelly. The composition may have a viscosity of from 300,000 to 500,000 c.p. at 20° C.
In some embodiments, the mouthwash composition may be substantially solid, for example it may take the form of a chewable jelly sweet or gum or lozenge. The composition may have a mass of from 5 to 15 g, or from 8 to 12 g.
In some embodiments the mouthwash composition is provided as a single dose or unit which has a mass appropriate for a single, comfortable mouthful. The mass may be typically 12 g for adults and 8 g for children. The mouthwash composition may conveniently be packaged in individually-wrapped doses. Thus according to a further aspect of the invention there is provided a package comprising a single dose or unit of mouthwash composition as hereinbefore described.
According to a further aspect of the invention there is provided the non-medical use of a mouthwash composition as hereinbefore described to clean teeth and/or freshen breath. Such use is a cosmetic use, i.e. cosmetic use of a mouthwash composition as hereinbefore described to clean teeth and/or freshen breath.
In some embodiments, the composition is formulated such that the concentration of each active ingredient achieved locally within the film that is formed on the buccal surfaces exceeds the Effective Dose_50. The composition may also be formulated such that excessive consumption does not result in the Lethal Dose_50 of any active ingredient being exceeded. For example, the composition may be formulated such that 400×12 g units must be consumed per day in order to exceed the Lethal Dose_50 for each active ingredient.
In some embodiments the composition comprises an antimicrobial agent. A mouthwash composition comprising an antimicrobial agent may be particularly suited for use by intubated patients, who often suffer from bacterial or fungal infections, such as an oral infection and/or pneumonia.
Thus, in a further aspect the invention provides a mouthwash composition for use in the treatment of infection in a patient, wherein the mouthwash composition comprises a heterogeneous gel comprising at least one antimicrobial agent.
The patient may be intubated.
The composition may be capable of providing controlled release of the antimicrobial agent over a period of time, for example at least 5 minutes, at least 10 minutes or at least 15 minutes.
The antimicrobial agent may be an antibiotic. The antibiotic may be a broad spectrum antibiotic. The antibiotic may be suitable for treating infection by Gram negative bacteria. Suitable antibiotics include polymixin E and tobramycin. In some embodiments, the antimicrobial agent is an antifungal (e.g. amphotericin B). In some embodiments, the composition comprises a combination of antimicrobial agents. The antimicrobial agent may be present in the composition in an amount of from 0.5 to 5%, or from 1 to 3%, e.g. 2% w/v.
In some embodiments, the mouthwash composition has at least some of the following properties:
According to a further aspect of the invention there is provided a method of preparing a mouthwash composition in the form of a gel as hereinbefore described, the method comprising:
In some embodiments the first and/or second component is in the form of a gel prior to mixing. Both the first and second components may be in the form of a gel prior to mixing. The gels are thus blended but not homogenized, thereby retaining different gel domains in the final composition which can provide differential release of active ingredients.
The first and/or second component in the form of a gel may be provided by dissolving a gelling agent in water with heating to form a solution and allowing the solution to cool so as to form a gel prior to mixing. One or more active ingredients may be added to the solution prior to cooling. The gel may be set partially or completely before mixing.
In some embodiments, the first and/or second component is in the form of a solution comprising a gelling agent. It will be appreciated that if the first and second components are mixed thoroughly while in the form of a solution, a homogeneous mixture will form. A heterogeneous mixture may be provided by incomplete mixing of the first and second components. In some embodiments, the first and/or second components may be cooled prior to mixing.
The method may further comprise a step of allowing the heterogeneous mixture to set so as to form the gel. The mixture may be allowed to set by cooling. In some embodiments, the method may additionally comprise adding a further gelling agent to the heterogeneous mixture prior to allowing the mixture to set.
A solution may be heated so as to dissolve the gelling agent. For example, a solution may be prepared by heating an amount of a liquid, such as water, and dissolving the gelling agent in the liquid.
In some embodiments, a first component in the form of a solution may be mixed with a second component which is in the form of a gel. The mixture may then be allowed to set, e.g. by cooling. This will form a heterogeneous gel which is a suspension of one component in the other.
In some embodiments, the method further comprises adding a colouring and/or a flavouring to the heterogeneous mixture.
In some embodiments the method further comprises coating or encapsulating the heterogeneous mixture. The heterogeneous mixture may be encapsulated by injecting the heterogeneous mixture into a hollow shell, such as a hollow sweet or lozenge. The heterogeneous mixture may be formed into soft gel capsules using, for example, a rotary die encapsulation process.
In some embodiments the method further comprises dispensing the mixture into a mould prior to allowing the mixture to set. Dispensing the mixture into a mould tray comprising multiple cavities enables individual doses of the mouthwash to be prepared.
It will be understood that the statements made above in relation to the first aspect of the invention may be applicable to any of the other aspects of the invention, and vice versa, as appropriate.
The invention will now be described by way of example and with reference to the following drawings in which:
Three different types of mouthwash were prepared: (1) a sports gel type having relatively low viscosity, (2) a jelly and (3) a lozenge.
1A. Protocol for the Production of 600 mL of Sports-Gel Style Mouthwash
This sports gel-style mouthwash requires gums to ensure a timely release of each of the active ingredients. Methylcellulose and xanthan gums were chosen for this application.
1B. Protocol for the Production of 600 mL of Sports-Gel Style Mouthwash
This sports-gel style mouthwash employs Gellans to allow the timely release of the active ingredients. Gellan Type F (low acyl) and Gellan Type LT100 (high acyl) were chosen.
2. Protocol for the Production of 600 g of a Jelly-Style Mouthwash
The jelly style mouthwash employs Gellans to allow the timely release of the active ingredients. Gellan Type F (low acyl) and Gellan Type LT100 (high acyl) were chosen.
3. Protocol for the Production of 600 mL of Wine Gum Style Mouthwash:
The wine gum style formulation involves the injection of 1 mL of the sports gel formulation into a vegetarian wine gum.
TABLE 1
Active Ingredient Formulation of a 12 g sample
of sports gel-style mouthwash
Formulation per
Mass fraction
Component
dose/mg
LD50 rat
(% w/w)
Xylitol
600
16,500
mg/kg
5.0%
Potassium nitrate
180
3,750
mg/kg
1.5%
Sorbitan
30 μL
36,700
μL/kg
0.25%
monolaurate
Peppermint oil
24 μL
2,426
mg/kg
0.18%
Menthol
3
3,300
mg/kg
0.025%
Eucalyptol
1.44 μL
2,480
mg/kg
0.011%
Thymol
0.36
980
mg/kg
0.0030%
Sodium fluoride
0.15
52
mg/kg
0.0013%
TABLE 2
Active Ingredient Formulation of a 4.4 g
sample of jelly-style mouthwash
Mass
Formulation per
fraction
Component
dose/mg
LD50 rat
(% w/w)
Xylitol
366.67
16,500
mg/kg
8.33%
Potassium nitrate
110
3,750
mg/kg
2.50%
Sorbitan
18.33 μL
36,700
μL/kg
0.43%
monolaurate
Peppermint oil
52.8 μL
2,426
mg/kg
0.39%
Menthol
1.83
3,300
mg/kg
0.042%
Eucalyptol
5.28 μL
2,480
mg/kg
0.041%
Thymol
0.22
980
mg/kg
0.0050%
Sodium fluoride
0.092
52
mg/kg
0.0021%
The concentration of peppermint oil and eucalyptol can be increased to reflect different sensitivities to peppermint.
TABLE 3
Formulation of peppermint oil for three different strengths
of sports gel-style mouthwash
Formulation per
Mass fraction
Formulation
dose/mg
LD50 rat
(% w/w)
‘100’
14.4 μL
2,426 mg/kg
0.11%
‘300’
24 μL
2,426 mg/kg
0.18%
‘500’
43.2 μL
2,426 mg/kg
0.32%
TABLE 4
Formulation of eucalyptol for three different strengths
of sports gel-style mouthwash
Formulation per dose/
Mass fraction
Formulation
mg
LD50 rat
(% w/w)
‘100’
1.44 μL
2,480 mg/kg
0.011%
‘300’
2.4 μL
2,480 mg/kg
0.018%
‘500’
4.32 μL
2,480 mg/kg
0.033%
TABLE 5
Formulation of peppermint oil for three different
strengths of jelly-style mouthwash
Mass
Formulation per dose/
fraction
Component
mg
LD50 rat
(% w/w)
‘100’
17.6 μL
2,426 mg/kg
0.35%
‘300’
52.8 μL
2,426 mg/kg
0.39%
‘500’
80.7 μL
2,426 mg/kg
1.65%
TABLE 6
Formulation of eucalyptol for three different strengths
of jelly-style mouthwash
Mass
Formulation per
fraction
Formulation
dose/mg
LD50 rat
(% w/w)
‘100’
1.76 μL
2,480 mg/kg
0.037%
‘300’
5.28 μL
2,480 mg/kg
0.11%
‘500’
8.07 μL
2,480 mg/kg
0.17%
TABLE 7
Gel Formulation for a sports gel-style mouthwash 12 g sample
Mass
Formulation
fraction
Component
per dose/mg
LD50 rat
(% w/w)
Methylcellulose
150
NA (too high)
2.0%
Xanthan
30
NA (too high)
0.20%
Water
10754 μL
90,000 mg/kg
89.63%
Colouring
144 μL
NA
1.20%
TABLE 8
Gel formulation for a jelly-style mouthwash based on 4.4 g sample
Formulation
Mass
per dose/
fraction
Component
mg
LD50 rat
(% w/w)
Gellan Type F (low acyl)
18.33
NA (too
0.42%
(Supplier Cream Supplies)
high)
Gellan Type LT100 (high
18.33
NA (too
0.42%
acyl)
high)
(Supplier Cream Supplies)
Water
3116 μL
90,000 mg/kg
70.82%
Food colouring
240 μL
NA
5.45%
Platinum Grade Leaf
160.45
NA
3.60%
Gelatin (Dr. Oetker)
Glycerine (Dr. Oetker)
260 μL
12,600 mg/kg
7.45%
Dissolution Tests
Dissolution Test 1
Six different mouthwash compositions (A-F) were prepared and formulated into 12 g units. Each composition contained a number of different active ingredients having a range of different molecular weights.
A single preparation unit (12 g) was added to a water-based solution maintained at 30° C. and stirred. Samples were removed from the supernatant at intervals forming a time course measurement. Each sample was then subject to electrospray ionization analysis with no preceding separation column. The variation in composition was then observed over time and plotted. The temporal dissolution profile of classes of molecules, grouped by mass (0-100, 100-200 etc.), is shown in
The dissolution profiles show that molecules of different mass class are released at different rates. Some have a single early phase which may be associated with surfactant and surfactant-soluble molecules; others show a later dissolution profile associated with the different phases in the gel formulation. Some mass classes show two peaks with contributions from different phases as they disperse into solution. It is believed that the composition of the film on the surface of the teeth, gum and cheek shows similar temporal dissolution behaviour as the composition of different mass classes in the mouth changes during the consumption of the gel. The film will be transient on the surface, further changing the composition time profile of the components. Any surface properties such as channels for the adsorption of K+ or oppositely charged surface groups and gel-phase species will be attracted and form an enhanced concentration-time profile. Similarly charged surface and gel-phase species will form depleted concentration-time profiles.
Dissolution Test 2
A sports-gel style mouthwash was prepared according to protocol 1B described above. In order to measure the release of the active ingredients from the mouthwash, it was necessary to recreate the mastication conditions of the mouth. The following protocol was employed for this purpose:
Prior to mass spectrometry analysis, the samples and standards obtained were diluted 1 part in 10 in acetonitrile (ACN). All concentrations given below for the calibration are of these diluted solutions.
All samples and calibration standards were injected in the following order: triplicate injections of full calibration standards from low to high concentration, triplicate injection of acetonitrile blank, triplicate injection of sample series B in timeline sequence (each with a single blank in between), single injection of full calibration standards from low to high concentration, triplicate injection of blank acetonitrile, triplicate injection of sample series B in timeline sequence (each with a single blank in between). The reason for the second, shorter, series of calibration standards was to determine if there was any significant decrease in sensitivity (indicated by decrease in peak area) during the batch.
The QTOF-UHPLC analysis was conducted using a MaXis HD quadrupole electrospray time-of-flight (ESI-QTOF) mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany) operated in ESI positive-ion MS mode. The QTOF was coupled to an Ultimate 3000 UHPLC (Thermo Fisher Scientific, California, USA). The capillary voltage was set to 4500 V, nebulising gas at 2 bar, drying gas at 10 L/min at 200° C. The TOF scan range was from 50-750 mass-to-charge ratio (m/z). For effective transmission of ions the ion energy was set to 1.0 eV with the collision energy for TOF MS acquisition at 2.0 eV. Liquid chromatography was performed using a Kinetex 1.7 μM, 2.1×100 mm HILIC column (Phenomenex) with a flow rate of 0.4 mL/min at 30° C. and an injection volume of 10 μL. Mobile phases A and B consisted of 50:50 ACN:H2O with 0.2% v/v formic acid and 10 mM ammonium formate, and 95:5 ACN:H2O with 0.2% v/v formic acid and 10 mM ammonium formate, respectively. Gradient elution was carried out with 100% mobile phase B until 2 min followed by a linear gradient to 0% B at 12 mins, keeping 0% B up until 15 mins, thereafter returned to 100% B until in 20 mins total run time. The MS instrument was calibrated using a range of sodium formate clusters introduced by 10 μL loop-injection prior to the chromatographic run. The mass calibrant solution consisted of 3 parts of 1 M NaOH to 97 parts of 50:50 water:isopropanol with 0.2% formic acid. The observed mass and isotope pattern perfectly matched the corresponding theoretical values as calculated from the expected elemental formula. Most of the target compounds were detected as [M+H]+ and [M+Na]+ ions. Data processing was performed using the Data Analysis software version 4.3 (Bruker Daltonik GmbH, Bremen, Germany). Quantification was carried out using the peak area in the extracted ion chromatogram (EIC) of the sum of the protonated and sodiated ion of the target compound. The calibration results are shown in Table 9 below.
TABLE 9
Time injected
Calibration range
Ingredient
(min)
(μg/mL)
R-squared
Thymol
0.8
0-9
0.98
Xylitol
2.5
0-10
0.97
Sorbitan
0.8
0-3
0.99
monolaurate
Glycerol
4.0
0-9
0.95
Eucalyptol
0.8
0-9
0.97
The calibration range was in the region of the calibration curve which gave a good linear calibration, and therefore excludes points outside this range. Menthol, potassium nitrate and sodium fluoride were not detected by this method.
Using the mass spectrometry data obtained, it is possible evaluate the release profiles of the active ingredients present in the sports-gel style mouthwash under simulated mastication conditions. A comparison of the individual release rate profiles for each active ingredient demonstrates the differential release profile of the mouthwash composition.
A comparison of each of the individual release profiles allows the differential and sequential release of effective amounts of the active ingredients to be observed over time. Thus
Shaw, Andrew Mark, Dow, Alasdair, Holdway, Tim
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
4994276, | Sep 19 1988 | PENWEST PHARMACEUTICALS CO | Directly compressible sustained release excipient |
5270031, | Dec 20 1991 | Block Drug Company Inc. | Dentinal desensitizing compositions |
5437856, | Dec 30 1992 | The Procter & Gamble Company | Oral compositions |
5900230, | Aug 18 1997 | Squigle, Inc. | Dental products to treat and prevent periodontal disease |
6485771, | Apr 22 1997 | Danisco Australia Pty Ltd | Edible compositions including particulated gel |
6685978, | Apr 04 2000 | CP Kelco ApS | Gelled and gellable compositions for food products |
20020081267, | |||
20040121061, | |||
20040180110, | |||
20040258733, | |||
20060024248, | |||
20070292372, | |||
20080081023, | |||
20090214445, | |||
20090318388, | |||
20100237281, | |||
20110305738, | |||
20130189202, | |||
20150272159, | |||
20160136192, | |||
20170326068, | |||
CN101534823, | |||
JP2003081794, | |||
JP2004300119, | |||
JP2012056870, | |||
JP2012193150, | |||
JP2013193969, | |||
WO3002056, | |||
WO2006081867, | |||
WO2014059679, | |||
WO2014156505, | |||
WO2015039277, | |||
WO9000387, | |||
WO9622701, | |||
WO2016129289, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Apr 28 2017 | ANDALAY TECHNOLOGIES LIMITED | (assignment on the face of the patent) | / | |||
Nov 07 2018 | HOLDWAY, TIM | ANDALAY TECHNOLOGIES LIMITED | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 051844 | /0671 | |
Nov 07 2018 | DOW, ALASDAIR | ANDALAY TECHNOLOGIES LIMITED | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 051844 | /0671 | |
Dec 06 2018 | SHAW, ANDREW MARK | ANDALAY TECHNOLOGIES LIMITED | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 051844 | /0671 |
Date | Maintenance Fee Events |
Oct 26 2018 | BIG: Entity status set to Undiscounted (note the period is included in the code). |
Nov 26 2018 | SMAL: Entity status set to Small. |
Date | Maintenance Schedule |
Jan 11 2025 | 4 years fee payment window open |
Jul 11 2025 | 6 months grace period start (w surcharge) |
Jan 11 2026 | patent expiry (for year 4) |
Jan 11 2028 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jan 11 2029 | 8 years fee payment window open |
Jul 11 2029 | 6 months grace period start (w surcharge) |
Jan 11 2030 | patent expiry (for year 8) |
Jan 11 2032 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jan 11 2033 | 12 years fee payment window open |
Jul 11 2033 | 6 months grace period start (w surcharge) |
Jan 11 2034 | patent expiry (for year 12) |
Jan 11 2036 | 2 years to revive unintentionally abandoned end. (for year 12) |